21 July 2022>: Clinical Research
Serum T Cell Immunoglobulin Mucin 3 Predicts Worse Prognosis in Hepatocellular Carcinoma Patients Undergoing Transcatheter Arterial Chemoembolization
Jun Li BCDE , Jing Wang ABCEF*DOI: 10.12659/MSM.935326
Med Sci Monit 2022; 28:e935326
Figure 6 Dynamic changes in serum Tim-3 during the peri-TACE period predicted poor prognosis. (A) Kaplan-Meier curve analysis for progression, in the training set, when patients were stratified according to their peri-TACE period serum Tim-3 levels. (B) Kaplan-Meier curve analysis for death, in the training set, when patients were stratified according to their peri-TACE period serum Tim-3 levels. Kaplan-Meier analyses were conducted and log-rank tests were performed. TACE – transcatheter arterial chemoembolization; Tim-3 – T cell immunoglobulin and mucin domain 3.